Jalra-Trio Forte Tablet SR
By Jalra Trio
10 Tablet SR in a Strip

Composition
Dapagliflozin(10mg) + Metformin(1000mg) + Vildagliptin(100mg)

Manufacturer - USV Private Limited
HPSIDC Ind. area ,Baddi ,Dist.Solan ,Himanchal Pradesh -173 205

Expires on or after
September, 2027

liver
Jalra-Trio Forte Tablet SR should not be used by patients with liver disease as it may be unsafe for them. It is advised to consult with your doctor before using this medication to ensure proper guidance and to avoid potential risks associated with liver issues.

kidney
Jalra-Trio Forte Tablet SR is safe for patients with kidney disease. No dose adjustment is needed.

alcohol
Caution is recommended when drinking alcohol with Jalra-Trio Forte Tablet SR. It is advisable to consult your doctor for guidance.

driving
It is advisable to avoid driving if Jalra-Trio Forte Tablet SR affects your concentration or reaction time. The impact on driving ability is not fully understood.

pregnancy
Jalra-Trio Forte Tablet SR may not be safe to use during pregnancy. Limited human studies suggest potential harm to the baby. Animal studies show harmful effects on the developing baby. Consult your doctor for personalized advice.

breastfeeding
Jalra-Trio Forte Tablet SR is possibly unsafe during breastfeeding. Limited data indicates it may pass into breastmilk and harm the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | - |
| Action Class | - |
₹156.91
₹184.6
15% OFF
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024
